以上结果表明，对于暴露于平均罹患卵巢癌风险的女性，筛查并不能降低癌症相关死亡率。
The findings thus suggest that, at least for women with an average risk of developing ovarian cancer, screening does not reduce cancer-related mortality.
如果Buys博士的研究结果正确，那么至少对于卵巢癌来说，筛查可能弊更大于利。
If Dr Buys is right, then, screening for cancer, at least of the ovaries, may do more harm than good.
在这一天到来之前，症状指标加CA125的筛查可能是诊断卵巢癌最好的方法。
Until that day comes, the symptoms index plus CA125 screening may be the best way to identify women who may have ovarian cancer.
在这一天到来之前，症状指标加CA125的筛查可能是诊断卵巢癌最好的方法。
Until that day comes, the symptoms index plus CA125 screening may be the best way to identify women who may have ovarian cancer.
应用推荐